High albuminuria in CKD: prevalence and characteristics in a real-world clinical setting

被引:0
|
作者
Svensson, Maria K. [1 ]
Bodegard, Johan [2 ]
Thuresson, Marcus [3 ]
Ambery, Philip [2 ]
机构
[1] Uppsala Univ, Uppsala, Sweden
[2] AstraZeneca, Gothenburg, Sweden
[3] Statisticon AB, Uppsala, Sweden
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
2661
引用
收藏
页码:I950 / I950
页数:1
相关论文
共 50 条
  • [21] Assessment of the prevalence and costs of osteoporosis treatment options in a real-world setting
    Brixner, D
    AMERICAN JOURNAL OF MANAGED CARE, 2006, 12 (07): : S191 - S198
  • [22] Clinical Characteristics and Disease Course of Fibrosing Interstitial Lung Disease Patients in a Real-World Setting
    Kilpelainen, Maritta
    Hirvonen, Tuuli
    Perkonoja, Katariina
    Hirsjarvi, Samuli
    MEDICINA-LITHUANIA, 2023, 59 (02):
  • [23] Design a Clinical Research Protocol: Influence of Real-World Setting
    Cimino, Jonathan
    Braun, Claude
    HEALTHCARE, 2023, 11 (16)
  • [24] NONCYSTIC FIBROSIS BRONCHIECTASIS CLINICAL PRACTICE IN THE REAL-WORLD SETTING
    Sadikot, Ruxana T.
    Feliciano, Joseph
    Odo, Nnaemeka
    Mohanty, Maitreyee
    Obradovic, Marko
    Veeranki, Phani
    CHEST, 2024, 166 (04) : 172A - 173A
  • [25] CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS REACHING A HIGH DAILY DOSE OF IDEGLIRA SIX MONTHS AFTER INITIATION IN A REAL-WORLD SETTING
    Prager, R.
    Price, H.
    Blueher, M.
    Fernandes, J.
    Moller, J. B.
    Schultes, B.
    VALUE IN HEALTH, 2018, 21 : S122 - S122
  • [26] Performance Characteristics of Breezhaler(R) and Aerolizer(R) in the Real-World Setting
    Molimard, Mathieu
    Kottakis, Ioannis
    Jauernig, Juergen
    Lederhilger, Sonja
    Nikolaev, Ivan
    CLINICAL DRUG INVESTIGATION, 2021, 41 (05) : 415 - 424
  • [27] CHARACTERISTICS AND TREATMENTS OF PATIENTS WITH SJOGREN'S SYNDROME IN A REAL-WORLD SETTING
    Gonzalez-Najera, Carlos
    Taylor, Steven
    Crawford, Sean
    Narasimhan, Premkumar
    Shao, Xiao
    Li Jun
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1161 - 1162
  • [28] Real-world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting
    Balasubramanian, Vijay P.
    Safdar, Zeenat
    Sketch, Margaret R.
    Broderick, Meredith
    Nelsen, Andrew C.
    Lee, Dasom
    Melendres-Groves, Lana
    PULMONARY CIRCULATION, 2022, 12 (01)
  • [29] Efficacy of Omalizumab in a real-world setting
    Sussman, Robert
    CHEST, 2007, 132 (04) : 512S - 512S
  • [30] Experience with dulaglutide in a real-world setting
    Zouras, S.
    Stephens, J. W.
    Price, D. E.
    Syed, W.
    DIABETIC MEDICINE, 2018, 35 : 186 - 186